Novartis to conduct strategic review of Sandoz division

Oct 26, 2021

Novartis disclosed in its Q3 2021 earnings announcement that it will undertake a strategic review of the Sandoz division. Novartis stated that this review will explore all options ranging from retaining the business to separation.

Print Page Mail Article